Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2024	Mar. 31, 2023
ASSETS
Cash and cash equivalents	$ 8,570	$ 6,398
Restricted cash and cash equivalents	2,251	2,090
Investments in marketable securities	4,505	5,037
Finance receivables, net of allowance for credit losses of $1,637 and $1,489, respectively	101,669	90,280
Investments in operating leases, net	28,013	29,869
Other assets	4,373	3,921
Total assets	149,381	137,595
LIABILITIES AND SHAREHOLDER'S EQUITY
Debt	122,420	111,685
Deferred income taxes	3,272	3,727
Other liabilities	6,707	5,674
Total liabilities	132,399	121,086
Commitments and contingencies (Refer to Note 9)
Shareholder's equity:
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at March 31, 2024 and 2023	915	915
Additional paid-in capital	2	2
Accumulated other comprehensive loss	(65)	(57)
Retained earnings	16,130	15,649
Total shareholder's equity	16,982	16,509
Total liabilities and shareholder's equity	$ 149,381	$ 137,595